ARTICLE
10 November 2022

SCOTUS Catches IP Fever

SS
Seyfarth Shaw LLP

Contributor

With more than 900 lawyers across 18 offices, Seyfarth Shaw LLP provides advisory, litigation, and transactional legal services to clients worldwide. Our high-caliber legal representation and advanced delivery capabilities allow us to take on our clients’ unique challenges and opportunities-no matter the scale or complexity. Whether navigating complex litigation, negotiating transformational deals, or advising on cross-border projects, our attorneys achieve exceptional legal outcomes. Our drive for excellence leads us to seek out better ways to work with our clients and each other. We have been first-to-market on many legal service delivery innovations-and we continue to break new ground with our clients every day. This long history of excellence and innovation has created a culture with a sense of purpose and belonging for all. In turn, our culture drives our commitment to the growth of our clients, the diversity of our people, and the resilience of our workforce.
Relevant to patent law, the Supreme Court granted certiorari to decide the issue of enablement for patents with so-called "genus claims.
United States Intellectual Property

The U.S. Supreme Court recently granted certiorari for two intellectual property cases—one relating to patents and another for trademarks.

Patent Case

Relevant to patent law, the Supreme Court granted certiorari to decide the issue of enablement for patents with so-called “genus claims.” Genus claims are directed to inventions that are functional in nature, and with several possibilities for carrying out that function.

The case at issue involves an invention directed to a monoclonal antibody that binds to one of several residues. Many different antibodies can bind to these residues—and the patent only describes a few examples among millions of potential options (including many that are not yet known). So the issue to be decided is: Did the patent owner disclose the invention with enough detail to enable someone in the field to make and use the invention?  More specifically, are a few examples enough or must one describe every example under the sun? Or perhaps it is impossible to provide the necessary support for genus claims and we should forget about them altogether?

This case is obviously one to watch for biotech patents, but could also have a spillover effect to mechanical and electric patents. Mechanical and electric patents often claim the invention with functional language such as “a clip coupled to a base.” In this extremely simple example, must the patent describe every manner of one item coupling to another? Glue? Fasteners? Zippers? Surely the law does not require such an exhaustive list.

It is interesting to note the Solicitor General had recommended against the Supreme Court accepting this case.

Trademark Case

The Supreme Court will also decide whether the owner of a U.S. trademark can recover damages for trademark infringement based on foreign sales. Trademarks, like many IP assets, are territorial. A U.S. trademark normally protects against consumer confusion only within the United States. However, the 10th Circuit Court of Appeals found the defendant's actions “diverted tens of millions of dollars of foreign sales from [the plaintiff] that otherwise would have ultimately flowed into the United States.” The court then affirmed a district court ruling that awarded damages to the trademark owner based on the substantial effect of the U.S.-based infringement on foreign sales.

Here, the Solicitor General implored the Supreme Court to accept the case, focusing on the domestic purpose of U.S. trademark law.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More